Walleye Trading’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.4K Sell
10,000
-70,900
-88% -$224K ﹤0.01% 3806
2025
Q4
$299K Buy
80,900
+47,500
+142% +$153K ﹤0.01% 3160
2025
Q3
$88.5K Buy
+33,400
New +$64.6K ﹤0.01% 3764
2025
Q1
Sell
-529,300
Closed -$1.16M 4210
2024
Q4
$1.16M Buy
529,300
+4,100
+0.8% +$9.56K ﹤0.01% 2052
2024
Q3
$867K Hold
525,200
﹤0.01% 2193
2024
Q2
$1.17M Sell
525,200
-49,800
-9% -$117K ﹤0.01% 1956
2024
Q1
$1.54M Sell
575,000
-478,700
-45% -$1.16M ﹤0.01% 1907
2023
Q4
$3.15M Buy
1,053,700
+949,600
+912% +$1.23M 0.01% 1564
2023
Q3
$102K Sell
104,100
-80,500
-44% -$116K ﹤0.01% 3956
2023
Q2
$257K Sell
184,600
-119,000
-39% -$166K ﹤0.01% 3275
2023
Q1
$483K Buy
303,600
+40,000
+15% +$206K ﹤0.01% 2833
2022
Q4
$1.64M Buy
263,600
+21,600
+9% +$154K ﹤0.01% 1843
2022
Q3
$1.62M Buy
242,000
+53,100
+28% +$365K ﹤0.01% 1865
2022
Q2
$1.2M Buy
188,900
+91,000
+93% +$516K ﹤0.01% 2059
2022
Q1
$454K Buy
97,900
+45,200
+86% +$194K ﹤0.01% 3002
2021
Q4
$264K Sell
52,700
-3,100
-6% -$24.8K ﹤0.01% 3615
2021
Q3
$672K Buy
55,800
+45,400
+437% +$661K ﹤0.01% 2633
2021
Q2
$220K Sell
10,400
-3,700
-26% -$89.1K ﹤0.01% 3821
2021
Q1
$396K Sell
14,100
-10,800
-43% -$319K ﹤0.01% 2917
2020
Q4
$647K Buy
+24,900
New +$746K ﹤0.01% 2425
2020
Q3
Sell
-10,500
Closed -$539K 4249
2020
Q2
$539K Buy
10,500
+1,000
+11% +$41.8K ﹤0.01% 2223
2020
Q1
$300K Sell
9,500
-4,800
-34% -$253K ﹤0.01% 2289
2019
Q4
$853K Buy
14,300
+7,300
+104% +$328K 0.01% 1941
2019
Q3
$257K Buy
7,000
+2,000
+40% +$79.2K ﹤0.01% 2734
2019
Q2
$233K Sell
5,000
-15,300
-75% -$719K ﹤0.01% 2828
2019
Q1
$815K Sell
20,300
-12,500
-38% -$561K 0.01% 1845
2018
Q4
$1.51M Buy
+32,800
New +$1.58M 0.01% 1303
2018
Q3
Sell
-6,900
Closed -$270K 5343
2018
Q2
$270K Buy
+6,900
New +$349K ﹤0.01% 3368

Other funds holding ESPR